{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:43:29Z","timestamp":1792417409905,"version":"4.4.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Magnetic resonance imaging (MRI)-negative lupus myelitis (MNLM) is a rare neurological manifestation of systemic lupus erythematosus (SLE). Diagnosing MNLM without prior systemic involvement remains challenging. This review aims to analyze all published cases and compare MNLM patients with (Group A) and without prior SLE diagnosis (Group B), emphasizing on demographic and clinical profiles, treatment, and outcomes. A PubMed literature review on MNLM was conducted. Demographic profile, clinical presentations, and management were analyzed. MNLM patients were categorized into Group A and B and compared using univariate and multivariate comparison methods, where a\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    value &lt;0.05 was considered significant. In total, 41 cases were analyzed. The cohort was predominantly female (8:1 ratio, mean age 31.22 \u00b1 11.91 years, range 15\u201359 years). Thoracic cord involvement was the most common (55%), with myelitis presenting as the first manifestation in 49% of patients. Clinical presentations were predominantly subacute (71%) with partial tract involvement in 63%. Group A demonstrated significantly higher cervical cord localization (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.019) compared to Group B\u2019s thoracic involvement (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.041). Antiphospholipid syndrome (APS) antibody-positive patients showed 3.2-fold higher odds for partial recovery (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.16). Logistic regression analysis identified Anti Smith\/ Ribonucleoprotein\/ Ribosomal (Sm\/RNP\/Rib) antibodies as independent risk factors for poor complete recovery (odds ratio (OR) = 0.61), whereas cervical cord localization independently improved odds for complete recovery (OR = 3.2). MNLM presents with variable clinical manifestations suggesting selective tract involvement. Group A exhibits higher cervical involvement, while Group B shows predominantly thoracic involvement. APS antibodies favor partial recovery, cervical localization predicts complete recovery, and Sm\/RNP\/Rib antibodies are independent predictors of poor recovery outcomes.\n                  <\/jats:p>","DOI":"10.4103\/aian.aian_1001_25","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T04:00:38Z","timestamp":1774411238000},"page":"150-162","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Magnetic Resonance Imaging-Negative Lupus Myelitis: A Narrative Review"],"prefix":"10.4103","volume":"29","author":[{"given":"Ashwin K","family":"Panda","sequence":"first","affiliation":[{"name":"Department of Neurology, Institute of Human Behaviour and Allied Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepti","family":"Grover","sequence":"additional","affiliation":[{"name":"Department of Neurology, Safdarjung Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshu","family":"Shakya","sequence":"additional","affiliation":[{"name":"Department of Neurology, Institute of Human Behaviour and Allied Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuber","family":"Shaikh","sequence":"additional","affiliation":[{"name":"Department of Neurology, Institute of Human Behaviour and Allied Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"R1-20261019","doi-asserted-by":"crossref","first-page":"16005","DOI":"10.1038\/scsandc.2016.5","article-title":"Myelitis in systemic lupus erythematosus: Clinical features, immunological profile and magnetic resonance imaging of five cases","volume":"2","author":"Hryb","year":"2016","journal-title":"Spinal Cord Ser Cases"},{"key":"R2-20261019","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","volume":"42","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R3-20261019","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12916-015-0269-8","article-title":"Neuropsychiatric lupus: A mosaic of clinical presentations","volume":"13","author":"Kivity","year":"2015","journal-title":"BMC Med"},{"key":"R4-20261019","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1002\/art.24937","article-title":"Distinct subtypes of myelitis in systemic lupus erythematosus","volume":"60","author":"Birnbaum","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R5-20261019","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.2147\/NDT.S267000","article-title":"Suspected transverse myelitis with normal MRI and CSF findings in a patient with lupus: What to do?A case series and systematic review","volume":"16","author":"Monahan","year":"2020","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R6-20261019","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/ard.48.2.160","article-title":"Transverse myelitis occurring during pregnancy in a patient with systemic lupus erythematosus","volume":"48","author":"Marabani","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"R7-20261019","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/jnnp.55.9.830","article-title":"Lupus-related myelopathy: Report of three cases and review of the literature","volume":"55","author":"Provenzale","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R8-20261019","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF00197524","article-title":"Central nervous system involvement in systemic lupus erythematosus: A new therapeutic approach with intrathecal dexamethasone and methotrexate","volume":"16","author":"Valesini","year":"1994","journal-title":"Springer Semin Immunopathol"},{"key":"R9-20261019","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/096120339600500409","article-title":"Transverse myelopathy in systemic lupus erythematosus: Clinical features and functional outcomes","volume":"5","author":"Chan","year":"1996","journal-title":"Lupus"},{"key":"R10-20261019","first-page":"91","article-title":"Transverse myelitis: A complication of systemic lupus erythematosus that is associated with the antiphospholipid syndrome","volume":"65","author":"Smyth","year":"1996","journal-title":"Ulster Med J"},{"key":"R11-20261019","first-page":"490","article-title":"Systemic lupus erythematosus associated with transverse myelitis and Parkinsonian symptoms","volume":"14","author":"Osawa","year":"1995","journal-title":"Clin Rheumatol"},{"key":"R12-20261019","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/ard.59.2.120","article-title":"Transverse myelopathy in systemic lupus erythematosus: An analysis of 14 cases and review of the literature","volume":"59","author":"Kovacs","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"R13-20261019","first-page":"280","article-title":"Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: Good functional outcome and relevance of antiphospholipid antibodies","volume":"31","author":"D'Cruz","year":"2004","journal-title":"J Rheumatol"},{"key":"R14-20261019","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4314\/wajm.v23i2.28113","article-title":"A case of neuropsychiatric lupus with myelopathy successfully treated with corticosteroids","volume":"23","author":"Salmi","year":"2004","journal-title":"West Afr J Med"},{"key":"R15-20261019","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/ard.2005.046615","article-title":"Mycophenolate mofetil for lupus related myelopathy","volume":"65","author":"Mok","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R16-20261019","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/0961203307088005","article-title":"Prognostic factors of lupus myelopathy","volume":"17","author":"Lu","year":"2008","journal-title":"Lupus"},{"key":"R17-20261019","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/0961203314547795","article-title":"Systemic lupus erythematosus-associated acute transverse myelitis: Manifestations, treatments, outcomes, and prognostic factors in 20 patients","volume":"24","author":"Saison","year":"2015","journal-title":"Lupus"},{"key":"R18-20261019","doi-asserted-by":"crossref","first-page":"31","DOI":"10.31138\/mjr.32.1.31","article-title":"Spectrum of myelitis in systemic lupus erythematosus: Experience from a single tertiary care centre over 25 years","volume":"32","author":"Mehta","year":"2021","journal-title":"Mediterr J Rheumatol"},{"key":"R19-20261019","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.1093\/rheumatology\/keab216","article-title":"MRI negative myeloradiculoneuropathy unmasking systemic lupus erythematosus","volume":"60","author":"Das","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"R20-20261019","doi-asserted-by":"crossref","first-page":"968322","DOI":"10.3389\/fneur.2022.968322","article-title":"Persistent \u201cMRI-negative\u201clupus myelitis-disease presentation, immunological profile and outcome","volume":"13","author":"Das","year":"2022","journal-title":"Front Neurol"},{"key":"R21-20261019","first-page":"42","article-title":"Magnetic resonance imaging-negative myeloneuropathy and bilateral facial paresis unfurling systemic lupus erythematosus","author":"Ghosh","year":"2022","journal-title":"Qatar Med J 2022"},{"key":"R22-20261019","doi-asserted-by":"crossref","first-page":"100133","DOI":"10.1016\/j.nerep.2022.100133","article-title":"MRI negative myelitis with selective tractopathy \u2013A distinct subtype of lupus myelitis","volume":"2","author":"Das","year":"2022","journal-title":"Neuroimmunol Rep"},{"key":"R23-20261019","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4103\/aian.aian_654_24","article-title":"MRI-Negative Central Nervous System SLE: A Unique Case Report","volume":"28","author":"Grover","year":"2025","journal-title":"Ann Indian Acad Neurol"},{"key":"R24-20261019","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1212\/WNL.0000000000004765","article-title":"Clinical biomarkers differentiate myelitis from vascular and other causes of myelopathy","volume":"90","author":"Barreras","year":"2018","journal-title":"Neurology"},{"key":"R25-20261019","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the SLEDAI. A disease activity index for lupus patients","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheum"},{"key":"R26-20261019","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jocn.2017.06.003","article-title":"Myelitis in systemic lupus erythematosus","volume":"44","author":"Li","year":"2017","journal-title":"J Clin Neurosci"},{"key":"R27-20261019","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12016-009-8192-4","article-title":"The unexplained female predominance of systemic lupus erythematosus: Clues from genetic and cytokine studies","volume":"40","author":"Weckerle","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"R28-20261019","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0961203318815768","article-title":"Sexual dimorphism in systemic lupus erythematosus: Above and beyond sex hormones","volume":"28","author":"Christou","year":"2019","journal-title":"Lupus"},{"key":"R29-20261019","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.reuma.2016.06.004","article-title":"Myelitis and systemic lupus erythematosus: Clinical manifestations, diagnosis and treatment","volume":"13","author":"Chiganer","year":"2017","journal-title":"Reumatol Clin"},{"key":"R30-20261019","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3390\/diagnostics14121225","article-title":"Diffusion tensor imaging identifies cervical spondylosis, myelitis, and spinal cord tumors","volume":"14","author":"Wang","year":"2024","journal-title":"Diagnostics"},{"key":"R31-20261019","doi-asserted-by":"crossref","first-page":"616","DOI":"10.7326\/0003-4819-83-5-616","article-title":"Transverse myelopathy in systemic lupus erythematosus","volume":"83","author":"Andrianakos","year":"1975","journal-title":"Ann Intern Med"},{"key":"R32-20261019","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/MAJ.0000000000000217","article-title":"The differential diagnosis of hypoglycorrhachia in adult patients","volume":"348","author":"Chow","year":"2014","journal-title":"Am J Med Sci"},{"key":"R33-20261019","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nrneurol.2010.126","article-title":"Extreme hypoglycorrhachia: Not always bacterial meningitis","volume":"6","author":"Viola","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"R34-20261019","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrrheum.2010.62","article-title":"Pathogenesis, diagnosis and management of neuropsychiatric systemic lupus erythematosus manifestations","volume":"6","author":"Bertsias","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"R35-20261019","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4081\/reumatismo.2012.350","article-title":"Therapeutic strategies in severe neuropsychiatric systemic lupus erythematosus: experience from a tertiary referral centre","volume":"64","author":"Bortoluzzi","year":"2012","journal-title":"Reumatismo"},{"key":"R36-20261019","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/0961203315622821","article-title":"Cyclophosphamide in combination with glucocorticoids for severe neuropsychiatric systemic lupus erythematosus: A retrospective, observational two-centre study","volume":"25","author":"Fanouriakis","year":"2016","journal-title":"Lupus"},{"key":"R37-20261019","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/ard.2010.130476","article-title":"EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations","volume":"69","author":"Bertsias","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R38-20261019","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/ard.2004.025528","article-title":"Controlled clinical trial of intravenous cyclophosphamide versus intravenous methylprednisolone in severe neurological manifestations in systemic lupus erythematosus","volume":"64","author":"Barile-Fabris","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R39-20261019","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002265.pub3","article-title":"Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus","author":"Fernandes Mo\u00e7a Trevisani","year":"2013","journal-title":"Cochrane Database Syst Rev 2013"},{"key":"R40-20261019","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.semarthrit.2011.06.004","article-title":"Rituximab therapy in refractory neuropsychiatric lupus: Current clinical evidence","volume":"41","author":"Narv\u00e1ez","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"R41-20261019","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/ard.2006.057885","article-title":"Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system","volume":"66","author":"Tokunaga","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R42-20261019","first-page":"911","article-title":"Lupus transverse myelopathy: Better outcome with early recognition and aggressive high-dose intravenous corticosteroid pulse treatment","volume":"81","author":"Subramony","year":"1988","journal-title":"Southern Med J"},{"key":"R43-20261019","first-page":"89","article-title":"Acute transverse myelitis in systemic lupus erythematosus: Magnetic resonance imaging and review of the literature","volume":"17","author":"Boumpas","year":"1990","journal-title":"J Rheumatol"},{"key":"R44-20261019","first-page":"370","article-title":"Transverse myelitis in systemic lupus erythematosus: The effect of intravenous pulse methylprednisolone and cyclophosphamide","volume":"19","author":"Barile","year":"1992","journal-title":"J Rheumatol"}],"container-title":["Annals of Indian Academy of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.aian_1001_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:03:20Z","timestamp":1792415000000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.aian_1001_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/aian.aian_1001_25","relation":{},"ISSN":["0972-2327","1998-3549"],"issn-type":[{"value":"0972-2327","type":"print"},{"value":"1998-3549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"2025-09-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}